These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline. Fuchs F; Hamprecht A J Antimicrob Chemother; 2019 Oct; 74(10):2934-2937. PubMed ID: 31292653 [TBL] [Abstract][Full Text] [Related]
5. Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline. Sobke A; Makarewicz O; Baier M; Bär C; Pfister W; Gatermann SG; Pletz MW; Forstner C Int J Antimicrob Agents; 2018 Feb; 51(2):213-220. PubMed ID: 29111434 [TBL] [Abstract][Full Text] [Related]
7. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C; Xie W; Zhang W; Ye Z; Wu H Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [TBL] [Abstract][Full Text] [Related]
8. Adaptations of carbapenem resistant Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918 [No Abstract] [Full Text] [Related]
12. Susceptibility of Aerococcus urinae and Aerococcus sanguinicola to Standard Antibiotics and to Nitroxoline. Ahmadzada A; Fuchs F; Hamprecht A Microbiol Spectr; 2023 Feb; 11(2):e0276322. PubMed ID: 36847493 [TBL] [Abstract][Full Text] [Related]
13. Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Petropoulou D; Siopi M; Vourli S; Pournaras S Front Cell Infect Microbiol; 2021; 11():814530. PubMed ID: 35127562 [TBL] [Abstract][Full Text] [Related]
14. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii. Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex. Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii. Seifert H; Stefanik D; Olesky M; Higgins PG Int J Antimicrob Agents; 2020 Jan; 55(1):105829. PubMed ID: 31669740 [TBL] [Abstract][Full Text] [Related]
17. Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates. Hoffmann AM; Wolke M; Rybniker J; Plum G; Fuchs F J Glob Antimicrob Resist; 2023 Jun; 33():1-4. PubMed ID: 36842457 [TBL] [Abstract][Full Text] [Related]
18. Han R; Ding L; Yang Y; Guo Y; Yin D; Wu S; Zhi P; Zhu D; Liu Q; Tan X; Zhu Y; Zhang J; Li L; Hu F Microbiol Spectr; 2022 Feb; 10(1):e0147121. PubMed ID: 35138143 [TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048 [TBL] [Abstract][Full Text] [Related]
20. Regulation of overexpressed efflux pump encoding genes by cinnamon oil and trimethoprim to abolish carbapenem-resistant Acinetobacter baumannii clinical strains. Saleh NM; Ezzat H; El-Sayyad GS; Zedan H BMC Microbiol; 2024 Feb; 24(1):52. PubMed ID: 38331716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]